Page 3 - Intel Deep Learning News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Diabetic Retinopathy Market Size is expected to reach USD 14.2 billion by 2026; Rising Incidences of Diabetes Globally to Stimulate the Market Growth iCrowd Newswire 03 Jun 2021, 02:38 GMT+10 The global Diabetic Retinopathy Market was valued at USD 10.1 billion in 2020 and is expected to reach USD 14.2 billion by 2026, exhibiting a CAGR of 5.8% during forecasted period 2020-2026. Global rise in incidences of diabetes coupled with vision concerns caused by prolonged diabetes are key factors contributing to the growth of Diabetic Retinopathy market. This comprehensive study on Diabetic Retinopa...

Intel has announced new 11th Gen Core H-series, vPro and Xeon processors. Aimed at gaming and business, these new high-performance CPU options should push the envelope for mobile processors. The new Core H processors, led by the flagship Core i9-11980HK, use Intel’s 10nm ‘SuperFin’ process technology, feature up to eight cores and 16 threads and have both single- and dual-core turbo performance up to 5GHz. Additionally, Intel notes that the H-series chips can directly access the fast GDDR6 memory attached to the GPU to help deliver higher frame rates and reduce latency. Intel’s Core H...

Mar 16, 2021 11:00 EDT with 35 comments After months of teasing and even being forced to tip its hand on a release date, Intel is finally detailing its 11th-generation desktop processors, codenamed Rocket Lake-S. While they're still built on a 14nm node, there's quite a bit that's new, including a new architecture with up to 19% IPC (instructions per clock cycle) improvement. They also come with all-new integrated graphics. Called UHD Graphics 750 but using Iris Xe architecture, Intel is promising up to a 50% boost over the previous generation. The family is also getting new AI ...

Intel-Powered AI Solution can Reduce Diabetic Vision Loss by Hannah Joy on  March 15, 2021 at 2:22 PM The solution can identify diabetic retinopathy (DR), greatly reducing the screening burden on vitreoretinal surgeons. "With Netra.AI, Sankara Eye Foundation and Leben Care have leveraged the power of Intel Xeon Scalable processors and built-in Intel Deep Learning (DL) Boost to accurately detect DR and enable timely treatment to effectively combat avoidable vision impairment and blindness in diabetic patients." Prakash Mallya, Vice President and Managing Director of Sales, M...

A team of experts has developed an Intel-powered comprehensive retina risk assessment software-as-a-service platform in India.Developed by Sankara Eye Foundation and Singapore-based Leben Care, Netra.AI is a cloud-based Artificial Intelligence ...